StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Verbindung

Idebenone

HCID 3686
Neue Reaktion
Drucken

Daten werden ergänzt – lade die Seite später neu, um den aktuellen Stand zu sehen

GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
58186-27-9
Standard-SMILES
COC1=C(OC)C(=O)C(CCCCCCCCCCO)=C(C)C1=O
InChIKey
JGPMMRGNQUBGND-UHFFFAOYSA-N
Summenformel
C19H30O5
Durchschnittliche Molmasse
338,4 g/mol
Monoisotopische Masse
338,20932405

Überblick

Idebenone is a member of the class of 1,4-benzoquinones which is substituted by methoxy groups at positions 2 and 3, by a methyl group at positions 5, and by a 10-hydroxydecyl group at positions 6. Initially developed for the treatment of Alzheimer's disease, benefits were modest; it was subsequently found to be of benefit for the symptomatic treatment of Friedreich's ataxia. It has a role as a ferroptosis inhibitor and an antioxidant. It is a member of 1,4-benzoquinones and a primary alcohol.

Namen und Bezeichner

Bevorzugter Name
Idebenone
IUPAC
2-(10-hydroxydecyl)-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione
Englischer Name
Idebenone
Summenformel
C19H30O5
Molmasse
338.44

Namen und Synonyme

idebenone58186-27-9IdebenonaRaxone2-(10-hydroxydecyl)-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dioneIdebenonumSovrimahydroxydecyl ubiquinoneCV 2619Oristar hdu2-(10-Hydroxydecyl)-5,6-dimethoxy-3-methyl-1,4-benzoquinoneCV-2619
Weitere Namen anzeigen
IdebenonAvandebenoneIdebenone powder6-(10-DarumaMnesisQSA-10
6-(10-Hydroxydecyl)-2,3-dimethoxy-5-methyl-1,4-benzoquinoneDTXSID0040678HB6PN45W4JCHEBI:31687NSC-7592282-(10-Hydroxydecyl)-5,6-dimethoxy-3-methyl-p-benzoquinone2,5-Cyclohexadiene-1,4-dione, 2-(10-hydroxydecyl)-5,6-dimethoxy-3-methyl-DTXCID8020678

Datenbank-Bezeichner

CAS
58186-27-9
PubChem CID
3686
DTXSID
DTXSID0040678
ChEMBL
CHEMBL252556
ChEBI
CHEBI:31687
UNII
HB6PN45W4J
EC Number
814-253-7
Nikkaji
J22.706D

Eigenschaften

Berechnete StruktureigenschaftenWird ergänzt

XLogP
4,3
Polarare Oberfläche (TPSA)
72,8 Ų
H-Brücken-Donoren
1
H-Brücken-Akzeptoren
5
Frei drehbare Bindungen
12
Schwere Atome
24
Formalladung
0
Komplexität
502

Experimentelle und physikochemische Eigenschaften

CosmeticsCosmetic ingredients (Hydroxydecyl Ubiquinone) -> CIR (Cosmetic Ingredient Review)
LogP2.96
Human DrugsEMA approved medicines: Human medicine
Collision Cross Section · 2 Einträge

181.21 Ų [M+K]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

178.6 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

Physikochemische Eigenschaften

Schmelzpunkt
52 · 52-550C
Siedepunkt
497.3 · 497.3±45.0 °C(Predicted)
Dichte
1.08 · 1.08±0.1 g/cm3(Predicted)
storage temp.
room temp
Löslichkeit
Soluble in DMSO (up to 25 mg/ml).
pka
15.2 · 15.20±0.10(Predicted)
Aggregatzustand
Solid
Farbe
Orange
Merck
14 · 14,4888
Stabilität
1 year · Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 3 months.
Kosmetik-Inhaltsstoffe Funktionen
ANTIOXIDANT
InChI
InChI=1S/C19H30O5/c1-14-15(12-10-8-6-4-5-7-9-11-13-20)17(22)19(24-3)18(23-2)16(14)21/h20H,4-13H2,1-3H3
InChIKey
JGPMMRGNQUBGND-UHFFFAOYSA-N
SMILES
C1(=O)C(OC)=C(OC)C(=O)C(C)=C1CCCCCCCCCCO
LogP
3.49 · 3.490 (est)
CAS Datenbank
58186 · 58186-27-9(CAS DataBase Reference)

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

GHS-Klassifizierung

GHS Classification · 5 Einträge

This chemical does not meet GHS hazard criteria for 25% (1 of 4) of reports.

Danger

H228 (25%): Flammable solid [Danger Flammable solids]

P210, P240, P241, P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P370+P378, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 4 reports by companies from 4 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Gefahrenhinweise

Hazard Classes and CategoriesFlam. Sol. 2 (25%)

Toxikologische Informationen

Toxicity SummarySafe in the present practices of use and concentration. Ingredient, concentration, and use information are available in documents discoverable at https://cir-reports.cir-safety.org

Sicherheitsdaten

wgk
3
hs_code
2933399990
RTECS-Nr.
GU5290000
hazard_code
Xi

Chemie und Industrie

Pharmakologische Informationen

ATC Code · 3 Einträge

N06BX13

N - Nervous system

QN - Nervous system

Mechanism of Action · 1 Eintrag

Idebenone is a synthetic analogue of ubiquinone (also known as Coenzyme Q10), a vital cell antioxidant and essential component of the Electron Transport Chain (ETC). It has been proposed that by interacting with the ETC, idebenone increases ATP production required for mitochondrial function, reduces free radicals, inhibits lipid peroxidation, and consequently protects the lipid membrane and mitochondria from oxidative damage. More specifically, idebenone is thought to transfer electrons directly to complex III of the mitochondrial ETC, thereby circumventing complex I and restoring cellular energy (ATP) generation.

Metabolism/Metabolites · 1 Eintrag

Metabolism occurs by means of oxidative shortening of the side chain and by reduction of the quinone ring and conjugation to glucuronides and sulphates. Idebenone shows a high first pass metabolism resulting in conjugates of idebenone (glucuronides and sulphates (IDE-C)) and the Phase I metabolites QS10, QS6, and QS4 as well as their corresponding Phase II metabolites (glucuronides and sulphates (QS10+QS10-C, QS6+QS6-C, QS4+QS4-C)). The main metabolites in plasma are IDE-C and QS4+QS4-C.

MeSH Pharmacological ClassificationNaturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues.
Absorption, Distribution and Excretion · 3 Einträge

After oral administration, idebenone is rapidly absorbed. On repeat dosing, maximum plasma concentrations of idebenone are reached on average within 1 hour (median 0.67 h range: 0.33-2.00 h). Food increases the bioavailability of idebenone by approximately 5-7-fold and i therefore should always be administered with food.

The main route of elimination is metabolism, with the majority of dose excreted via the kidneys as metabolites. After a single or repeated oral dose of 750 mg of idebenone, QS4+QS4-C were the most prominent idebenone-derived metabolites in urine, representing on average between 49.3% and 68.3% of the total administered dose. QS6+QS6 represented 6.45% to 9.46%, whereas QS10+QS10-C and IDE+IDE-C were close to 1% or below.

Experimental data have shown that idebenone passes the blood-brain barrier and is distributed at significant concentrations in cerebral tissue. Following oral administration pharmacologically relevant concentrations of idebenone are detectable in the aqueous humor of the eye.

Verwendung und Herstellung

UsesCIR ingredient: Hydroxydecyl Ubiquinone
Anwendungen · 2 Einträge

BeschreibungIdebenone is an organic compound belonging to the quinone family, being similar to coenzyme Q-10. It is a kind of drug developed by Takeda Pharmaceutical Company for the treatment of Alzheimer’s disease and some other cognitive defects. However, these have been not very much progress associated with this indication. It is now also used for the treatment of Friedreich’s ataxia with a positive effect on cardiac hypertrophy and neurological function. However, this indication is only approved in Canada, not in Europe and US. It is now under investigation on its efficacy for the treatment of Duchenne muscular dystrophy, Leber’s hereditary optic neuropathy, mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes) as well as primary progressive multiple sclerosis. The efficacy of this drug still demands more evidences.

Verwendenidebenone is an anti-oxidant capable of protecting the skin from a variety of free-radical attacks, including the formation of secondary chemicals that negatively affect skin physiology. It is said to improve intrinsic as well as extrinsic skin damage caused by freeradical formation. Idebenone is a synthetically manufactured form of coenzyme Q10 and has a smaller molecular structure. This allows it to penetrate the skin and apparently the cellular membrane. Clinical studies demonstrate a visible improvement in photodamaged skin, reduced skin roughness and dryness, decreased fine lines and wrinkles, and increased skin hydration. In addition, idebenone helps improve hyperpigmentation because its molecular structure is similar to that of hydroquinone. Although most of the associated benefits are seen primarily in the epidermis, some increase in dermal collagen has also been confirmed. Idebenone has been used for such health-related problems as Alzheimer’s and heart disease.

Vor- und nachgelagerte Produkte

Vorgelagerte Rohstoffe

n-HexanN,N-Dimethylformamid4-Phenylazophenylen-1,3-diaminmonohydrochlorid10-acetoxycarbonyl chlorideKresolKaliumdihydrogenorthophosphatDichlormethan3,4,5-Trimethoxytoluol

Nachgelagerte Produkte

Idebenone Sulfate
Ergänzende Hinweise · 1 Eintrag

DefinitionChEBI: Idebenone is a member of the class of 1,4-benzoquinones which is substituted by methoxy groups at positions 2 and 3, by a methyl group at positions 5, and by a 10-hydroxydecyl group at positions 6. Initially developed for the treatment of Alzheimer's disease, benefits were modest; it was subsequently found to be of benefit for the symptomatic treatment of Friedreich's ataxia. It has a role as an antioxidant and a ferroptosis inhibitor. It is a primary alcohol and a member of 1,4-benzoquinones.

Zugehörige Reaktionen

38
Reaktionsaufzeichnung erstellen
Reaktionsgleichung von HRID 147968
HRID 147968als Edukt
Reaktionsgleichung von HRID 299093
HRID 299093als Produkt
Reaktionsgleichung von HRID 370412
HRID 370412als Edukt
Reaktionsgleichung von HRID 580246
HRID 580246als Edukt
Reaktionsgleichung von HRID 637893
HRID 637893als Produkt
Reaktionsgleichung von HRID 637894
HRID 637894als Produkt
Reaktionsgleichung von HRID 637895
HRID 637895als Produkt
Reaktionsgleichung von HRID 637896
HRID 637896als Produkt
ZurückSeite 1 von 5

Notizen zur Verbindung

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung